Skip to main content
. 2021 Mar 20;2(1):19–31. doi: 10.17816/CP66

Table 2. Table 2. Clinical indicators of patients included in the study.

Scale Episodic schizophrenia (n=20) Continuous schizophrenia (n=16) t-test
PANSS total 89.9 [81.1, 98.7] 112.6 [105.5, 119.7] t=4.075; p<0.001
PANSS P 24.1 [20.2, 28] 25.6 [21.4, 29.8] t=0.550; p=0.586
PANSS N 20.6 [17.1, 24.1] 32.9 [30.3, 35.5] t=5.675; p<0.001
PANSS G 45.2 [41.4, 49] 53.8 [50.2, 57.4] t=3.397; p=0.002
BFCRS 6 [2.6, 9.4] 8.3 [3.3, 13.3] t=0.830; p=0.413
NSA-4 13.7 [11.6, 15.8] 24.2 [21.7, 26.7] t=6.837; p<0.001
Simpson-Angus Scale (SAS) 1.6 [0.7, 2.5] 2.4 [1.4, 3.4] t=1.254; p=0.219
Symptom severity scale of the DSM5 for schizophrenia (SS-DSM5) 12.3 [11.1, 13.5] 15.4 [14.1, 16.7] t=3.682; p=0.001
Frontal assessment battery (FAB) 15.1 [14.3, 15.9] 13.2 [12.1, 14.3] t=-3.022; p=0.005